Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16056
Title: Fosfomycin for treatment of prostatitis: new tricks for old dogs
Austin Authors: Grayson, ML;Macesic, N;Trevillyan, J ;Ellis, AG;Zeglinski, PT;Hewitt, NH;Gardiner, BJ;Frauman, AG
Affiliation: Department of Infectious Diseases, Austin Health Department of Medicine, University of Melbourne
Department of Medicine, University of Melbourne Department of Clinical Pharmacology, Austin Health, Melbourne, Australia
Department of Infectious Diseases, Austin Health.
Department of Infectious Diseases, Austin Health Department of Infectious Diseases, Alfred Health.
Department of Medicine, University of Melbourne.
Issue Date: 1-Oct-2015
metadata.dc.date: 2015-06-10
Publication information: Clinical Infectious Diseases 2015; 61(7): 1141-1143
Abstract: Treatment options for prostatitis caused by multidrug-resistant gram-negative bacilli are limited. We report two cases cured with oral fosfomycin and provide a pharmacokinetic analysis of fosfomycin predose concentrations during treatment.
Description: Editorial Commentary: Fosfomycin: The Current Status of the Drug. Clin Infect Dis. 2015, vol. 61(7) p. 1144-6. doi: 10.1093/cid/civ443
URI: http://ahro.austin.org.au/austinjspui/handle/1/16056
DOI: 10.1093/cid/civ436
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/26063723
Type: Journal Article
Subjects: Fosfomycin
Microbial drug resistance
Pharmacology
Prostatitis
Type of Clinical Study or Trial: Case Series and Case Reports
Appears in Collections:Journal articles

Show full item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.